Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam (Intranasal vs Nebulized) for Dental Sedation in Preschoolers
NCT05883150Phase 3Completed
- Start
- Nov 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of midazolam in Dental anxiety (2 arms). Primary endpoint: Behavior rating. Started Nov 2022; status: completed.
02
Drugs
midazolam
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on NCT05883150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05883150.